891 related articles for article (PubMed ID: 23235605)
1. Dietary interventions for multiple sclerosis.
Farinotti M; Vacchi L; Simi S; Di Pietrantonj C; Brait L; Filippini G
Cochrane Database Syst Rev; 2012 Dec; 12():CD004192. PubMed ID: 23235605
[TBL] [Abstract][Full Text] [Related]
2. Dietary interventions for multiple sclerosis.
Farinotti M; Simi S; Di Pietrantonj C; McDowell N; Brait L; Lupo D; Filippini G
Cochrane Database Syst Rev; 2007 Jan; (1):CD004192. PubMed ID: 17253500
[TBL] [Abstract][Full Text] [Related]
3. Dietary interventions for multiple sclerosis-related outcomes.
Parks NE; Jackson-Tarlton CS; Vacchi L; Merdad R; Johnston BC
Cochrane Database Syst Rev; 2020 May; 5(5):CD004192. PubMed ID: 32428983
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
[TBL] [Abstract][Full Text] [Related]
5. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids for the treatment of dementia.
Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
[TBL] [Abstract][Full Text] [Related]
7. Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.
Schindler T; Sinn JK; Osborn DA
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD010112. PubMed ID: 27788565
[TBL] [Abstract][Full Text] [Related]
8. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews.
Griffith RJ; Alsweiler J; Moore AE; Brown S; Middleton P; Shepherd E; Crowther CA
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012394. PubMed ID: 32526091
[TBL] [Abstract][Full Text] [Related]
9. Polyunsaturated fatty acids in multiple sclerosis therapy.
Wergeland S; Torkildsen Ø; Bø L; Myhr KM
Acta Neurol Scand Suppl; 2012; (195):70-5. PubMed ID: 23278660
[TBL] [Abstract][Full Text] [Related]
10. Long-chain polyunsaturated fatty acid supplementation in infants born at term.
Simmer K; Patole SK; Rao SC
Cochrane Database Syst Rev; 2008 Jan; (1):CD000376. PubMed ID: 18253974
[TBL] [Abstract][Full Text] [Related]
11. Specially formulated foods for treating children with moderate acute malnutrition in low- and middle-income countries.
Lazzerini M; Rubert L; Pani P
Cochrane Database Syst Rev; 2013 Jun; (6):CD009584. PubMed ID: 23794237
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment for memory disorder in multiple sclerosis.
He D; Zhang Y; Dong S; Wang D; Gao X; Zhou H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008876. PubMed ID: 24343792
[TBL] [Abstract][Full Text] [Related]
13. [Polyunsaturated fatty acids for multiple sclerosis treatment: scientific evidence].
Kong-González M; Pérez-Cortéz JG; Hernández-Girón C; Macías-Morales N; Flores-Aldana M
Medwave; 2015 Jan; 15(1):e6062. PubMed ID: 25628005
[TBL] [Abstract][Full Text] [Related]
14. Early intervention for psychosis.
Marshall M; Rathbone J
Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone for multiple sclerosis.
Martinelli Boneschi F; Vacchi L; Rovaris M; Capra R; Comi G
Cochrane Database Syst Rev; 2013 May; (5):CD002127. PubMed ID: 23728638
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids for intermittent claudication.
Sommerfield T; Price J; Hiatt WR
Cochrane Database Syst Rev; 2007 Oct; (4):CD003833. PubMed ID: 17943801
[TBL] [Abstract][Full Text] [Related]
17. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
18. Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
La Mantia L; Di Pietrantonj C; Rovaris M; Rigon G; Frau S; Berardo F; Gandini A; Longobardi A; Weinstock-Guttman B; Vaona A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009333. PubMed ID: 27880972
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
20. Herbal and dietary therapies for primary and secondary dysmenorrhoea.
Proctor ML; Murphy PA
Cochrane Database Syst Rev; 2001; (3):CD002124. PubMed ID: 11687013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
